The CDC recommends that immunocompromised people age 65 and older should get a second dose of the 2024-2025 COVID vaccine.

The Centers for Disease Control and Prevention (CDC)’s Advisory Committee on Immunization Practices (ACIP) is recommending that the age for pneumococcal vaccination be lowered from 65 to 50 years.

As the weather starts to cool down and we spend more time gathered together indoors, the risk of contracting an illness rises ...

Each year, the U.S. sees roughly 30,000 cases of invasive pneumococcal disease, which includes blood infections, brain and ...

All adults aged 50 and older should receive a vaccine against bacteria that can cause pneumonia and meningitis, federal ...

The drug was also evaluated in the PURPOSE-1 trial (NCT04994509), which compared lenacapavir as PrEP to alternative daily PrEP with Truvada or Gilead’s Descovy (emtricitabine and tenofovir ...

The drug was also evaluated in the PURPOSE-1 trial (NCT04994509), which compared lenacapavir as PrEP to alternative daily PrEP with Truvada or Gilead’s Descovy (emtricitabine and tenofovir alafenamide ...

The Centers for Disease Control and Prevention (CDC) has announced the five health departments that will receive federal funding to provide generic pre-exposure prophylaxis (PrEP) to prevent HIV as ...

The move involves the company’s long-acting cabotegravir (CAB LA), a PrEP medication made from one of the active ingredients in the company’s HIV treatment Cabenuva. The drug was the first ...

In its warning, the CDC noted that the counterfeit pills frequently contained fentanyl and methamphetamine. The problem is pervasive: According to the National Association of Boards of Pharmacy, ...

CHARLESTON, W.Va. — President of the Drug Intervention Institute in Charleston Dr. Susan Margaret Murphy said the numbers recently released by the CDC showing an over 11% decline in overdose ...

In both studies, Apretude was compared to Truvada, an HIV PrEP regimen recommended by the CDC and the United States Public Health Service. Each trial lasted 153 weeks. At the end of each trial ...